Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 78 citing articles:

Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 331
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Qian Song, Xiang Zhang
Biomedicines (2022) Vol. 10, Iss. 3, pp. 524-524
Open Access | Times Cited: 80
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
Kui Wang, Li Luo, Shuyue Fu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut–liver axis
Xiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Modulating phenylalanine metabolism by L. acidophilus alleviates alcohol-related liver disease through enhancing intestinal barrier function
Liuying Chen, Pengcheng Yang, Lilin Hu, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
Xingyun Wu, Zihao Wang, Li Luo, et al.
Frontiers in Medical Technology (2023) Vol. 4
Open Access | Times Cited: 22
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles
Yongjie Deng, Yao Yao, Yanni Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Integrative Metabolomic Characterization Reveals the Mediating Effect of Bifidobacterium breve on Amino Acid Metabolism in a Mouse Model of Alzheimer’s Disease
Guangsu Zhu, Min Guo, Jianxin Zhao, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 735-735
Open Access | Times Cited: 27
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 17
TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway
Renshun Dong, Tianci Wang, Wei Dong, et al.
Journal of Hepatology (2025)
Closed Access
Recent advances and potentiality of phenyllactic acid: source, antimicrobial mechanism, and applications
Yuwei Sun, Jiang Zhu, Tao Wang, et al.
Trends in Food Science & Technology (2025), pp. 104926-104926
Closed Access
Applications of liquid chromatography-mass spectrometry based metabolomics in predictive and personalized medicine
Juntuo Zhou, Lijun Zhong
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 26
Small molecules in the big picture of gut microbiome-host cross-talk
Yue Ma, Xiaolin Liu, Jun Wang
EBioMedicine (2022) Vol. 81, pp. 104085-104085
Open Access | Times Cited: 25
Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients
Xiaoyue Li, Yongxiang Yi, Tongxin Wu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
Zhong-Chen Li, Jie Wang, He-Bin Liu, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113877-113877
Open Access | Times Cited: 4
Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease
Shiman Jiang, Lvwan Xu, Yanfei Chen, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 6, pp. 1183-1198
Open Access | Times Cited: 4
Exposure to synthesized tribromobisphenol A and critical effects: Metabolic pathways, disease signature, and benchmark dose derivation
Hong-Xuan Kuang, Chenyin Dong, Lei Yan, et al.
The Science of The Total Environment (2024) Vol. 932, pp. 173117-173117
Closed Access | Times Cited: 4
Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer
Hongyan Gou, Ruijie Zeng, Harry Cheuk-Hay Lau, et al.
Pharmacological Research (2024) Vol. 208, pp. 107373-107373
Open Access | Times Cited: 4
Aqueous Extract of Rhubarb Promotes Hepatotoxicity via Facilitating PKM2-Mediated Aerobic Glycolysis in a Rat Model of Diethylnitrosamine-Induced Liver Cancer
Anni Zhao, Xiaomei Liu, Xiping Chen, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4497-4510
Open Access | Times Cited: 3
Role of Micronutrients and Gut Microbiota-Derived Metabolites in COVID-19 Recovery
Teresita de Jesús Hernández-Flores, Eliza Julia Pedraza‐Brindis, Jhonathan Cárdenas-Bedoya, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12324-12324
Open Access | Times Cited: 17
Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice
Tingting Wang, Xiaoting Huang, Kefeng Zhai, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 115893-115893
Closed Access | Times Cited: 16
Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC
Noor UA. Nazir, Shah Rukh Abbas
Analytica Chimica Acta (2022) Vol. 1242, pp. 340752-340752
Closed Access | Times Cited: 16
The mechanism of action of Ophiocordyceps sinensis mycelia for prevention of acute lung injury based on non-targeted serum metabolomics
Jinna Zhou, Na Pi, Yingqi Guo, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0287331-e0287331
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top